hotspot -WSS

hotspot

author：entertainment 2025-09-27 12:35:09 - browse：9

Andrew Witty, Chief Executive Officer of UnitedHealth Group, testifies at a Senate Finance Committee hearing examining cyber attacks.-- health tech coverage from STAT — UnitedHealth Group CEO Andrew Witty said the company was beginning to see a “disturbance” in its Medicaid medical costs. Jacquelyn Martin/AP

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

What’s next for Risant?

Kaiser Permanente grabbed everyone’s attention last year when it said it was creating Risant Health, a new and vague entity that acquired Geisinger and had plans to scoop up at least four more health systems that are focused on “value-based care.”

Well, nothing has happened since then, at least publicly. Instead, everyone has been playing the parlor game of guessing who those next systems could be. There are some rumblings that the next deal could be announced in the near future. After reading some recent hospital financial reports, it’s clear there are a handful of systems that mirror Geisinger’s shaky trajectory and could find themselves in Kaiser’s crosshairs.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

WSS

J&J to buy cancer drug developer Ambrx Biopharma

R1 RCM gets $5.8 billion buyout offer from private equity firm

Antibiotic resistance and the global rise in human conflict

Feng Zhang CRISPR delivery startup lays off quarter of staff

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

R1 RCM gets $5.8 billion buyout offer from private equity firm

Wikipedia

hotspot

What’s next for Risant?

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Apple is now the first public company to be valued at $3 trillion

The FDA must approve intranasal treatments for anaphylaxis

The high cost of giving birth even with insurance

JPM: CVS says Medicare Advantage patients are impacting profits

Alkermes shareholders re

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Novavax promises a turnaround & Lilly roils the obesity market

Dario to buy mental health app maker Twill in cash and stock deal

Hollywood unions extend contract negotiations for actors

Federal weight loss drug coverage is 30 years out of date

hotspot

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Videos point to link between seizures and unexplained toddler deaths

Dario to buy mental health app maker Twill in cash and stock deal

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Videos point to link between seizures and unexplained toddler deaths

Wikipedia

hotspot

leisure time

Wikipedia